The Analyst Verdict: Blue Bird In The Eyes Of 4 Experts
4 analysts have expressed a variety of opinions on Blue Bird (NASDAQ:BLBD) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 0 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 2 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $45.0, a high estimate of $52.00, and a low estimate of $40.00. Observing a 13.92% increase, the current average has risen from the previous average price target of $39.50.
Investigating Analyst Ratings: An Elaborate Study
The perception of Blue Bird by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Chris Pierce | Needham | Raises | Buy | $52.00 | $44.00 |
Craig Irwin | Roth MKM | Raises | Buy | $40.00 | $35.00 |
Chris Pierce | Needham | Maintains | Buy | $44.00 | - |
Chris Pierce | Needham | Announces | Buy | $44.00 | - |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Blue Bird. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing ...
Full story available on Benzinga.com